Human leukocyte antigen-DR negative de novo acute myeloid leukemia with Philadelphia chromosome.
Inaba
Tohru
T
Department of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. inaba178@koto.kpu-m.ac.jp.
Nishimura
Hiroshi
H
Faculty of Clinical Laboratory, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Saito
Junko
J
Faculty of Clinical Laboratory, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yamane
Yoko
Y
Faculty of Clinical Laboratory, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Nakatani
Takuya
T
Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yamamoto
Mio
M
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Uchiyama
Hitoji
H
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Fujita
Naohisa
N
Department of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage; D006684:HLA-DR Antigens; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010677:Philadelphia Chromosome; D012074:Remission Induction
D006684:HLA-DR Antigens; D003561:Cytarabine; D015255:Idarubicin